PD-L1 methylation restricts PD-L1/PD-1 interactions to control cancer immune surveillance
Sign Up to like & getrecommendations! Published in 2023 at "Science Advances"
DOI: 10.1126/sciadv.ade4186
Abstract: Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) or programmed cell death 1 ligand 1 (PD-L1) have enabled some patients with cancer to experience durable, complete treatment responses; however, reliable anti–PD-(L)1 treatment response… read more here.
Keywords: methylation; k162 methylation; cancer immune; immune surveillance ... See more keywords